Abstract:Objective To investigate the changes of serum adiponectin and visfatin/pre-B cell colony-enhan cing factor(PBEF)levels in patients with metabolic syndrome(MS),so as to understand their association with MS.Methods According to the diagnostic criteria for MS recommended by the Chinese Medical Association in 2004,42 patients with MS were selected for this study with 30 healthy subjects as the control group.After mea- surement of the height,body weight and waist circumference,fasting blood samples were collected from all partici- pants to determine the fasting plasma glucose(FPG),serum insulin,adiponectin and visfatin levels.Radioimmuno- assay(RIA)was employed for serum adiponectin level measurement;enzyme-linked immunoassay(EIA)was used for visfatin detection;and homeostasis model assessment of insulin resistance(HOMA-IR)was calculated based on FPG and insulin measurements.Results①There were 22 males and 20 females in the MS group,with a mean age of(53±10)years old;there were 18 males and 12 females in the control group,with a mean age of(49±10) years.The ages and sex structure were matchable between the two groups(both P>0.05).②Serum visfatin levels was significantly higher in the MS patients than in the control subjects([97.57±40.69]μg/L vs [50.54±19.14]μg/L,P<0.05),but the adiponectin level was significantly lower([7.98±3.62] mg/L vs [13.55±5.72] mg/L,P<0.01).③In patients with MS,serum visfatin level was positively correlated with the waist circumference(Satandard partial regression cofficient=0.415,P=0.000),but not with other metabolic indices such as adiponectin,serum insulin,body mass index,HOMA-IR,or triglycerol;adiponectin level was positively correlated with high-density lipoprotein cholesterol(HDL-C)level(Satandard partial regression cofficient=0.312, P=0.004)but inversely with HOMA-IR(Satandard partial regression cofficient=-0.341,P=0.002)and the waist-hip ratio(Satandard partial regression cofficient=-0.211,P=0.048).Conclusions Significantly elevated visfatin and decreased adiponeetin levels occur in MS patients.Visfatin may play a role in the development of viscer al obesity,and adiponectin may inhibit insulin resistance and dyslipidiemia.No obvious correlation between visfatin and adiponectin is suggested.

Correlation of Plasma Visfatin with Type 2 Diabetes Mellitus

Correlations of Serum Visfatin and Metabolisms of Glucose and Lipid in Women with Gestational Diabetes Mellitus

A Research on Correlation between Serum Visfatin and Glucose and Lipid Metabolism among Women with Gestational Diabetes Mellitus

VEGF Levels in Plasma in Relation to Metabolic Control, Inflammation, and Microvascular Complications in Type-2 Diabetes A Cohort Study

Plasma Visfatin Levels in Patients with Newly Diagnosed and Untreated Type 2 Diabetes Mellitus and Impaired Glucose Tolerance

Study on the relationship between plasma visfatin levels and newly diagnosed patients with type 2 diabetes of Han autonomous in Henan

Changes of Serum Visfatin,Adiponectin and Leptin Levels in Patients with Type 2 Diabetes Mellitus

The Visfatin Gene is Associated with Glucose and Lipid Metabolism in a Chinese Population.

Association of Plasma Concentration of Visfatin with Obesity and Metabolic Parameters in Chinese Han Adults

Relationship between Plasma Phospholipid Fatty Acid Profile and Insulin Resistance in Type 2 Diabetics

Association of Visfatin with Blood Glucose, Insulin Resistance and Body Mass Index in Patients with Type 2 Diabetes/Pre-Diabetes

Study on the Relationship Between Serum Visfatin and Eldly Type 2 Diabetes Mellitus with Macrovascular Lesion

Correlation Between Pancreatic Fat Content and Type 2 Diabetes Mellitus

Relationship study of blood serum visfatin and iron metabolism in newly diagnosed type 2 diabetes mellitus

Visceral fat correlates with insulin secretion and sensitivity independent of BMI and subcutaneous fat in Chinese with type 2 diabetes

Change of Retinol Binding Protein-4 Concentrations in Patients with Type 2 Diabetes Mellitus and Its Relationship with Glucose and Lipid Metabolism

Recent Advances on the Relationship Between Visfatin and Type 2 Diabetes Mellitus

Correlation of serum visfatin and adiponectin levels with metabolic syndrome

Correlation between fat distribution and cardiovascular risk in Chinese type 2 diabetes

Study on correlation between distribution of abdominal adipose tissue and insulin resistance in patients type 2 diabetes mellitus complicating obesity

Correlation Between Serum Levels of Adipose Triglyceride Lipase and Obesity and Diabetes Mellitus